Litigation

• Eli Lilly, Others Urge 6^th Circ. To Toss Darvocet Appeal (subscription required)
• McNeil Asks Pa. Appeals Court to Boot $10M Motrin Verdict (subscription required)
• J&J to Pay $4B to Settle Hip Implant Suits (subscription required)
• J&J Trying to Back Out of 77 Risperdal Deals, Plaintiffs Say (subscription required)
• Birth Defect Lawyers in Effexor MDL Assigned to Leadership Roles
• Final Bard Avaulta Vaginal Mesh Bellweather Trial Set for Dec. 3
• Stryker Rejuvenate Hip Attorneys Assigned to leadership Positions in MDL
• Process Outlined for Selecting First Pradaxa Trials in Federal Litigation
• Whistleblower Payment to Top $165M in Johnson and Johnson Settlement
• J&J Unit Levied $400M, Admits Off-Label Risperdal Marketing (subscription required)

Regulatory

• FDA Rips Aegerion Exec for Drug Promo Claims on CNBC (subscription required)
• Juxtapid Maker Gets FDA Warning Letter Over Misleading Statements
• Brilinta Problems Continue for AstraZeneca, as EU Questions Clinical Trials
• FDA Labeling Rule Creates Liability Risk for Generic Cos. (subscription required)
• FDA Rule Would Allow Generics Makers to Update Labels (subscription required)
• FDA Proposed Generic Drug Rules Could Solve Preemption Problem
• FDA Notes Increase in Reports Involving Surgical Robot Injuries, Complications
• FDA Needs Rule Change from DMAA Crackdown, Suit Says (subscription required)

Recalls

• Atossa Genetics Mammary Aspiration Specimen Cytology Test (MASCT) System Kit and ForeCYTE Breast Health Test – Marketing Without Approval or Clearance
• OxyElite Pro Dietary Supplements by USP Labs: Recall – Products Linked to Liver Illness
• Baylis Medical TorFlex Transseptal Guiding Sheath Kit

Other Interesting Reads

• NY High Court Mulls Smokers’ Medical Monitoring Claims (subscription required)
• New Heart Guidelines May Increase Use of Crestor, Lipitor and Other Statins

For a look at last week’s important life science headlines, click here.